Accessing the European Pharma Market: becoming a MAH through dossier adaptation (II)

The European pharma market is becoming more competitive and accessible through its effort to adopt globally acknowledged standards and requirements, it is not surprising the increasing interest of investors to this appealing market. When a non-European company is considering investing in EU business opportunities different strategies may be implemented depending on the company needs. One…